debt repayment, trade and other payables, therefore there is an increase in cash rates. - Net cash flows from the investing activities was 7.0 MB, increased by 4.6 MB when compare with Q2/2019 due to the

Analysis For 2Q20 and 6M20 P a g e | 8 As of 30 June 2020, the Company had Interest bearing debt to equity attributable to owners of the Company (IBD/E) ratio at 3.20 times and IBD/E ratio excluding TFRS 16

investment in subsidiary, operating gain of subsidiary disposed during the year, gain on disposal of investment in joint venture and gain on debt deduction of DEAN & DELUCA, Inc. Exhibit 3: Details and

, the Company would like to report the progress of this transaction that during Q4/2019 Wuttisak Clinic sent the notification letter to TPN requesting the debt payment. In addition, Wuttisak Clinic

25.51 Net Profit Margin (%) 2.35 3.18 3.55 Current Ratio (Times) 1.43 1.51 1.28 Debt to Equity Ratio (Times) 1.81 1.48 1.76 Book Value per Share (Baht) 2.25 2.39 2.39 Net Profit per Share (Baht) 0.43 0.57

million or down by 7.22%, resulted from lower cost of debt from refinancing bond issued in 4th quarter of 2020 and 1st quarter of 2021. 7. Income tax expenses were Baht 331.08 million, an increase of Baht

financial instruments were derived from a variety of activities, including, derivative warrants (DWs), over-the-counter (OTC) derivatives, investments in debt and equity securities for the Company’s own

group as no net interest bearing debt and operating working capital is positive the groups funding is from the shareholders equity. Page 2 of 3 Major Factors which could have an Impact on the Company's

from pre-acquisition level of 35% to 56% by end of 2019. IRSL refinanced its outstanding debt with banks in India and managed to reduce cost of financing for funded long term facility by 8% p.a. and for

working capital to continue the business in the future. The Company has also no debt from loans. The Company still has a consistent assessment of financial impact on the value of assets and contingent